» Articles » PMID: 12856218

Smallpox Vaccination: a Review, Part II. Adverse Events

Overview
Journal Clin Infect Dis
Date 2003 Jul 12
PMID 12856218
Citations 101
Authors
Affiliations
Soon will be listed here.
Abstract

Smallpox vaccination of health care workers, military personnel, and some first responders has begun in the United States in 2002-2003 as one aspect of biopreparedness. Full understanding of the spectrum of adverse events and of their cause, frequency, identification, prevention, and treatment is imperative. This article describes known and suspected adverse events occurring after smallpox vaccination.

Citing Articles

A Pseudovirus Nanoparticle Displaying the Vaccinia Virus L1 Protein Elicited High Neutralizing Antibody Titers and Provided Complete Protection to Mice against Mortality Caused by a Vaccinia Virus Challenge.

Huang P, Xia M, Vago F, Jiang W, Tan M Vaccines (Basel). 2024; 12(8).

PMID: 39203972 PMC: 11359793. DOI: 10.3390/vaccines12080846.


Pathological skin manifestations following smallpox vaccination (ACAM2000) in US military personnel, 2009-2023: a systematic review.

Rehman S Proc (Bayl Univ Med Cent). 2024; 37(5):851-857.

PMID: 39165802 PMC: 11332642. DOI: 10.1080/08998280.2024.2372745.


T Cell Surveillance during Cutaneous Viral Infections.

Pei L, Hickman H Viruses. 2024; 16(5).

PMID: 38793562 PMC: 11126121. DOI: 10.3390/v16050679.


Functional epitopes and neutralizing antibodies of vaccinia virus.

Peng F, Hu N, Liu Y, Xing C, Luo L, Li X Front Microbiol. 2023; 14:1255935.

PMID: 37954238 PMC: 10634548. DOI: 10.3389/fmicb.2023.1255935.


Recombinant proteins A29L, M1R, A35R, and B6R vaccination protects mice from mpox virus challenge.

Tang D, Liu X, Lu J, Fan H, Xu X, Sun K Front Immunol. 2023; 14:1203410.

PMID: 37435062 PMC: 10331816. DOI: 10.3389/fimmu.2023.1203410.